Patents matching “The United States of America”

US 8729053

Nuclear factor kappa B pathway inhibitor composition and use of same

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 20, 2014 · Expires May 15, 2034

US 8728488

Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted May 20, 2014 · Expires May 15, 2034

US 8722653

Method for treating uterine fibroids

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 13, 2014 · Expires May 8, 2034

US 8722046

Human monoclonal antibodies protective against bubonic plague

The United States of America as represented by the Secretary of the Army · Granted May 13, 2014 · Expires May 8, 2034

US 8722063

Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

The United States of America, as represented by the Secretary of Agriculture · Granted May 13, 2014 · Expires May 8, 2034

US 8715591

Microfluidic apparatus to control liposome formation

The United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology · Granted May 6, 2014 · Expires May 1, 2034

US 8715751

Artemisinins in the clinical and veterinary management of kinetoplastid infections

The United States of America as represented by the Secretary of the Army · Granted May 6, 2014 · Expires May 1, 2034

US 8716460

Pseudomonas AVR and HOP proteins, their encoding nucleic acids, and use thereof

The United States of America, as represented by the Secretary of Agriculture · Granted May 6, 2014 · Expires May 1, 2034

US 8716315

Analogs of thalidomide as potential angiogenesis inhibitors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

US 8716301

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

US 8715689

Chimeric west nile/dengue viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted May 6, 2014 · Expires May 1, 2034

US 8715686

Conformationally stabilized HIV envelope immunogens

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

US 8710185

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army · Granted Apr 29, 2014 · Expires Apr 24, 2034

US 8710026

MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

US 8709487

Nanoparticle entrapment of materials

The United States of America as represented by the Secretary of the Army · Granted Apr 29, 2014 · Expires Apr 24, 2034

US 8709813

DNA promoters and anthrax vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

US 8703150

Methods of using Bacillus anthracis protective antigen sequences for vaccination

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

US 8703762

Method of treating organophosphorous poisoning

The United States of America as repr. by the Sec. of the Army, U.S. Army Med. Resr. Inst. of Chem. Defense · Granted Apr 22, 2014 · Expires Apr 17, 2034

US 8703096

Beta-amyloid PET imaging agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

US 8703826

Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Apr 22, 2014 · Expires Apr 17, 2034

US 8703921

Compositions and methods for delivering inhibitory oligonucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

US 8697666

Anti-cancer oligodeoxynucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2014 · Expires Apr 10, 2034

US 8697046

Methods of administering interferon gamma to absorb fluid from the subretinal space

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2014 · Expires Apr 10, 2034

US 8697856

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army · Granted Apr 15, 2014 · Expires Apr 10, 2034